Department of Internal Medicine, Keio University School of Medicine, 1608582 Tokyo, Japan.
Int J Environ Res Public Health. 2018 May 9;15(5):947. doi: 10.3390/ijerph15050947.
The efficacy of diabetes treatment should not be evaluated solely by HbA1c levels as they should also focus on patient-reported outcomes (PROs), such as patient satisfaction, wellbeing and quality of life. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) has been developed to assess patient satisfaction with diabetes treatment. DTSQ has been translated into more than 100 languages and is widely used in many countries, since it is relatively easy to answer and is used for both patients with and without medical therapy. Novel therapeutic options, such as insulin analogs, incretin-based therapy and sodium-glucose cotransporter 2 (SGLT2) inhibitors, have been shown to improve patient satisfaction using DTSQ for assessments. DTSQ is not only used for comparisons between different medications or treatment strategies, but also can be used to assess the quality of diabetes care in clinical settings. This is important as an improvement in treatment satisfaction may enhance patients' self-efficacy and adherence to therapy, leading to the achievement of long-term stable glycemic control and reduced risk of diabetic complications. In this review, we summarize the current topics in DTSQ, introducing our own experience, and discuss the role of PROs in diabetes treatment.
糖尿病治疗的疗效不应仅通过 HbA1c 水平来评估,还应关注患者报告的结局 (PROs),如患者满意度、幸福感和生活质量。糖尿病治疗满意度问卷 (DTSQ) 的开发是为了评估患者对糖尿病治疗的满意度。DTSQ 已被翻译成 100 多种语言,并在许多国家广泛使用,因为它相对容易回答,并且用于有和没有医疗治疗的患者。新型治疗选择,如胰岛素类似物、基于肠促胰岛素的治疗和钠-葡萄糖共转运蛋白 2 (SGLT2) 抑制剂,已经通过 DTSQ 评估显示出可以提高患者的满意度。DTSQ 不仅用于比较不同的药物或治疗策略,还可用于评估临床环境中的糖尿病护理质量。这一点很重要,因为治疗满意度的提高可以增强患者的自我效能和对治疗的依从性,从而实现长期稳定的血糖控制并降低糖尿病并发症的风险。在这篇综述中,我们总结了 DTSQ 的当前研究热点,介绍了我们自己的经验,并讨论了 PROs 在糖尿病治疗中的作用。